Furthermore, PD-L1, a common inhibitor of CD8a T cell–mediated immunotherapy via the programmed cell death protein 1 (PD1)/PD-L1 axis, can be expressed in primary breast tumors by local macrophages (21). The gene discussed is PDCD1; the disease is breast neoplasm.